CSF1R and glioblastoma: To the best of our knowledge, we first developed an efficient glioblastoma treatment paradigm of membrane‐targeted mild photothermal‐immunotherapy with lipophilic NIR‐II emissive probe (IRC18)‐loaded liposome and genetically engineered IL12/CSF1R‐macrophage membrane hybrid nanovesicles.